The meeting will take place in CLAPP HALL.
Arrive at the Hovorka Atrium, at the center of the Millis Science Center Building, 2080 Adelbert Road Cleveland, OH 44106-7080. (Click here for a Campus Map to locate the Millis Science Center).Check-in begins Monday, May 23, 2016 at 7:00 a.m. in the Hovorka Atrium. Questions can be answered by emailing us directly at ccmeec@case.edu.
Start | End | Speaker | Title | Venue |
---|---|---|---|---|
07:30 | 08:30 | Continental breakfast | Atrium | |
Session I: Introduction | ||||
08:30 | 08:40 | CWRU President Snyder | Welcome | Clapp 108 |
08:40 | 09:00 | Arnold Caplan | Introduction / Overview of Center – External Advisory Committee (EAC) introduction | Clapp 108 |
09:00 | 09:10 | Rosemarie Hunziker | Intro to P41 mechanism and goals | Clapp 108 |
09:10 | 09:20 | Joe Jankowski | Tech transfer – IP – innovation | Clapp 108 |
Session II: TR&D-4 — Objective: Specific Aims, progress, and collaborations | ||||
09:20 | 09:35 | Joseph Mansour | Overview of TR&D-4 | Clapp 108 |
09:35 | 09:45 | Kyriacos Athanasiou | (CP-1): Assessing repair outcomes in in relation to nondestructive preimplantation properties of TE constructs | Clapp 108 |
09:45 | 09:55 | Kirk Shung | (CP-8): Developing a linear array ultrasound transducer for real-time cartilage damage detection | Clapp 108 |
09:55 | 10:05 | Jennifer Elisseef | (SP-4): Imaging and friction in cartilage engineered with HA binding technology | Clapp 108 |
10:05 | 10:20 | Discussion | Clapp 108 | |
10:20 | 10:35 | Break | Atrium | |
Session III: TR&D-1 — Objective: Specific Aims, progress, and collaborations | ||||
10:35 | 10:50 | Zhenghong Lee | Overview of TR&D-1 | Clapp 108 |
10:50 | 11:00 | Ivan Martin | (CP-15): Nasal chondrocytes for the treatment of articular osteoarthritic lesions | Clapp 108 |
11:00 | 11:10 | Jim Dennis | (CP-2): Tissue engineered constructs for articular cartilage repair | Clapp 108 |
11:10 | 11:25 | Discussion | Clapp 108 | |
Session IV: TR&D-2 — Objective: Specific Aims, progress, and collaborations | ||||
11:25 | 11:40 | Rodrigo Somoza / Diego Correa | Overview of TR&D-2 | Clapp 108 |
11:40 | 11:50 | Chul-Won Ha | (CP-5): In vitro and in vivo characterization of chondrogenic differentiation of MSCs derived from novel sources | Clapp 108 |
11:50 | 12:00 | Eben Alsberg | (SP-1): Driving tissue formation by inductive stem cell sheet technology | Clapp 108 |
12:00 | 12:15 | Discussion | Clapp 108 | |
12:15 | 13:15 | Lunch break | Atrium | |
Session V: TR&D-3 — Objective: Specific Aims, progress, and collaborations | ||||
13:15 | 13:30 | Hari Baskaran | Overview of TR&D-3 | Clapp 108 |
13:30 | 13:40 | Farshid Guilak * | (CP-4): Scaffold-mediated gene delivery for engineering of osteochondral tissues | Clapp 108 |
13:40 | 13:50 | Rocky Tuan * | (CP-10 & SP-9): Regenerative repair of traumatic articular cartilage injuries: point-of-care application of mesenchymal stem cells and chondrocytes | Clapp 108 |
13:50 | 14:00 | Antonios Mikos | (SP-11): Injectable cellular composites for cartilage engineering. | Clapp 108 |
14:00 | 14:15 | Discussion | Clapp 108 | |
Session VI: Breakout Sessions — Objective: Goals and logistics for next 12 months | ||||
14:15 | 15:45 | Concurrent organizational small-group meetings between EAC members, TR&D and CP/SP PIs: |
I - David Kaplan (by WebEX) / Zhenghong Lee / Ivan Martin / Jim Dennis II - Suneel Apte / Rodrigo Somoza / Diego Correa / Chul-Won Ha / Eben Alsberg III - Robert Guldberg / Hari Baskaran / Rocky Tuan*/ Farsh Guilak*/ Tony Mikos IV - Kirk Shung / Joseph Mansour / Kyriacos Athanasiou / Jennifer Elisseeff |
Clapp 304 Clapp 405 Millis 123 Millis 220B |
15:45 | 16:00 | Entire group reconvenes | Atrium | |
16:00 | 17:00 | TR&D PI’s report to EAC (10 min report, 5 min Q&A) | Clapp 108 | |
17:00 | 17:30 | Other business | Clapp 108 | |
Session VII: Executive Session — Objective: EAC advice for next 12 months | ||||
17:30 | 18:00 | EAC and PI/co-PI | Clapp 108 | |
17:30 | 18:00 | Drinks and hors d’oeuvres | Atrium | |
18:00 | 20:00 | Dinner | Atrium | |
NOTES: * Drs Guilak and Tuan are unable to attend for personal reasons, we will present their slides for discussion |